Emergence of Legionella pneumophila Pneumonia in Patients Receiving Tumor Necrosis Factor- Antagonists | Zendy

Florence Tubach | Zendy; Philippe Ravaud | Zendy; Dominique SalmonCéron | Zendy; Nadine Petitpain | Zendy; Olivier Brocq | Zendy; Franck Grados | Zendy; J C Guillaume | Zendy; J Leport | Zendy; Anne Roudaut | Zendy; Elisabeth SolauGervais | Zendy; Marc Lémann | Zendy; Xavier Mariette | Zendy; Olivier Lortholary | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Emergence of Legionella pneumophila Pneumonia in Patients Receiving Tumor Necrosis Factor- Antagonists

Author(s) -

Florence Tubach,

Philippe Ravaud,

Dominique SalmonCéron,

Nadine Petitpain,

Olivier Brocq,

Franck Grados,

J C Guillaume,

J Leport,

Anne Roudaut,

Elisabeth SolauGervais,

Marc Lémann,

Xavier Mariette,

Olivier Lortholary

Publication year - 2006

Publication title -

clinical infectious diseases

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 3.44

H-Index - 336

eISSN - 1537-6591

pISSN - 1058-4838

DOI - 10.1086/508538

Subject(s) - medicine , infliximab , legionella pneumophila , etanercept , pneumonia , adalimumab , rheumatoid arthritis , surgery , gastroenterology , tumor necrosis factor alpha , biology , bacteria , genetics

Patients treated with tumor necrosis factor-alpha (TNF-alpha) antagonists have an increased risk of infection, but infection due to Legionella pneumophila has rarely been described in patients receiving such therapy.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research